Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

UK5

Inherited Cancer Genetic Testing

  • First published: 16 September 2025
  • Last modified: 16 September 2025
  • Record interest

     

  • This file may not be fully accessible.

  •  

Contents

Summary

OCID:
ocds-h6vhtk-059b82
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
16 September 2025
Deadline date:
-
Notice type:
UK5
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.

Full notice text

Scope

Procurement reference

CAV-DCO (25-26) 85

Procurement description

This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.

Contracting authority

Cardiff and Vale University Health Board

Identification register:

  • GB-PPON

Address 1: Woodland House, Maes-Y-Coed Road

Town/City: Cardiff

Postcode: CF14 4HH

Country: United Kingdom

Website: http://nwssp.nhs.wales/ourservices/procurement-services/

Public Procurement Organisation Number: PPPR-7969-BTJG

Contact name: nicola

Email: nicola.williams33@wales.nhs.uk

Organisation type: Public authority - sub-central government

Devolved regulations that apply: Wales

Supplier

Informed Genetics

Identification register:

  • GB-PPON

Address 1: Unit 5, quinton business park, 11 Ridgeway,

Town/City: Birmingham

Postcode: B32 1AF

Country: United Kingdom

Public Procurement Organisation Number: PZXY-1897-VDDJ

Email: Izzie.Coakley@nonacus.com

Type:

  • Large

Procedure

Procedure type

Direct award

Description of how these justifications apply

The decision to proceed with a direct award to the current supplier is based on the supplier’s proven track record of delivering consistent, high-quality service and their deep understanding of our operational requirements. Maintaining continuity with the existing supplier ensures minimal disruption, preserves established workflows, and avoids the additional costs and risks associated with transitioning to a new provider. Furthermore, the supplier has demonstrated a strong commitment to partnership and continuous improvement, aligning well with our strategic objectives.

Direct award justification

Single suppliers technical reasons

Contract terms and risks

Description of risks to contract performance

Changing suppliers at this stage presents several risks to contract performance, including potential service disruption, loss of operational continuity, and increased costs associated with onboarding a new provider. The current supplier has established familiarity with Cardiff and Vale university Health Board systems and processes, and replacing them could lead to delays, reduced efficiency, and quality issues during the transition period. Maintaining the existing relationship helps mitigate these risks and ensures consistent delivery aligned with organisational expectations.

Lots

Divided into 1 lots

Lot number: 1 Status: Complete

Contract

Inherited Cancer Genetics

ID: 1

Status: Pending

Related lots

1

Date the contract will be signed (estimated)

06 October 2025, 23:59PM

Value

450000.00 GBP Excluding VAT

540000.00 GBP Including VAT

Main category

Services

CPV classifications

  • 85148000 - Medical analysis services

Delivery regions

  • UKL22 - Cardiff and Vale of Glamorgan

Is the total value above threshold?

Above threshold

Contract dates (estimated)

01 January 2026, 00:00AM to 31 December 2026, 23:59PM

Suppliers

  • GB-PPON-PZXY-1897-VDDJ

Coding

Commodity categories

ID Title Parent category
85148000 Medical analysis services Miscellaneous health services

Delivery locations

ID Description
1022 Cardiff and Vale of Glamorgan

About the buyer

Main contact:
n/a
Admin contact:
n/a
Technical contact:
n/a
Other contact:
n/a

Further information

Date Details

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.